Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Pediatría resistente a la meticilina"'
Autor:
Beltrán-Higuera, Sandra Jaqueline, Palacios-Ariza, María Alejandra, Mancera-Gutiérrez, Luz Angela, Velandia-Páez, Jessica Paola, Camacho-Moreno, Germán, Ortiz-Mendez, Cesar Alfredo, Rojas-Rojas, Diana Paola, Romero-Higuera, Laura Natalia, Gómez-Cortés, Leydi Cristina, Vásquez-Hoyos, Pablo, Sosa-Rodríguez, Yeni Andrea, Brand-López, Katherine, Gutiérrez, Iván Felipe, Camacho-Cruz, Jhon, Wilches Cuadros, María Angélica, Hernandez-Vargas, Juan Camilo
Publikováno v:
Magill SS, O’Leary E, Janelle SJ, et al; Emerging Infections Program Hospital Prevalence Survey Team. Changes in prevalence of health careassociated infections in U.S. hospitals. N Engl J Med. 2018;379:1732–1744.
Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
Zervou FN, Zacharioudakis IM, Ziakas PD, et al. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133:e1015–e1023.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–33.
David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep. 2013;1:170–181.
Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. Available at: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance-antimicrobial-resistanceEurope-2019.pdf. Accessed November 30, 2020.
Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137:e20153099.
Song X, Cogen J, Singh N. Incidence of methicillin-resistant Staphylococcus aureus infection in a children’s hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg microbes & infect. 2013;2:e69.
Sáenz Moncaleano V. Boletín Informativo: resultados de la vigilancia de la resistencia bacteriana Año 2018 componente pediátrico y adulto. Universidad Nacional de Colombia; 2018:26.
Márquez-Ortiz RA, Álvarez-Olmos MI, Escobar Pérez JA, et al; Research Group of Pediatric Infectious Diseases. USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. Int J Infect Dis. 2014;25:88–93.
Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541–554.
John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin North Am. 2006;53:699–713.
Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC infectious diseases. 2012;12:260
Klieger SB, Vendetti ND, Fisher BT, et al. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36:603–605.
Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917.
Davis WT, Gilbert SR. Comparison of methicillin-resistant versus Susceptible Staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285–e291.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
Zervou FN, Zacharioudakis IM, Ziakas PD, et al. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133:e1015–e1023.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–33.
David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep. 2013;1:170–181.
Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. Available at: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance-antimicrobial-resistanceEurope-2019.pdf. Accessed November 30, 2020.
Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137:e20153099.
Song X, Cogen J, Singh N. Incidence of methicillin-resistant Staphylococcus aureus infection in a children’s hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg microbes & infect. 2013;2:e69.
Sáenz Moncaleano V. Boletín Informativo: resultados de la vigilancia de la resistencia bacteriana Año 2018 componente pediátrico y adulto. Universidad Nacional de Colombia; 2018:26.
Márquez-Ortiz RA, Álvarez-Olmos MI, Escobar Pérez JA, et al; Research Group of Pediatric Infectious Diseases. USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. Int J Infect Dis. 2014;25:88–93.
Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541–554.
John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin North Am. 2006;53:699–713.
Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC infectious diseases. 2012;12:260
Klieger SB, Vendetti ND, Fisher BT, et al. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36:603–605.
Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917.
Davis WT, Gilbert SR. Comparison of methicillin-resistant versus Susceptible Staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285–e291.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Antecedentes: La epidemiología de Staphylococcus aureus resistente a la meticilina (MRSA) y S. aureus sensible a la meticilina (MSSA) ha cambiado en los últimos años. El presente artículo tiene como objetivo establecer las diferencias entre los h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bbf5ea7eb38df6d63eddeeba4ea435f
https://repository.urosario.edu.co/handle/10336/37949
https://repository.urosario.edu.co/handle/10336/37949
